CellSearch Biotech is developing next-generation imaging tools to support safer, more effective cell and gene therapies. Their proprietary PET reporter technology is engineered to be invisible to the immune system, enabling non-invasive monitoring of T-cell therapies in patients. By revealing early signs that a therapy may fail or provoke toxic side effects (for instance in the brain), CellSearch Biotech’s platform gives clinicians critical time to adjust treatment strategies. This capability helps improve patient safety, accelerate therapy development and reduce wasted costs in clinical trials. CellSearch Biotech was founded to bring precision, real-time insights into cell therapy management, advancing innovation in cancer treatment globally.